In this mammography screening cohort, we found that insulin-treated T1D and T2D patients had higher MD levels as compared with age-matched individuals without diabetes and diabetes patients receiving other noninsulin glucose-lowering medication. This evidence concerns the gene INS and type 2 diabetes mellitus.